We are analyzing https://link.springer.com/article/10.1007/s10549-006-9279-8.

Title:
Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells | Breast Cancer Research and Treatment
Description:
Metastatic breast cancer cells exhibit the selective ability to seed and grow in the skeleton. We and others have previously reported that human breast tumors which metastasize to the skeleton overexpress bone matrix extracellular proteins. In an attempt to reveal the osteoblast-like phenotype of osteotropic breast cancer cells, we performed a microarray study on a model of breast cancer bone metastasis consisting of the MDA-MB-231 human cell line and its variant B02 selected for its high capacity to form bone metastases in vivo. Analysis of B02 cells transcriptional profile revealed that 11 and 9 out of the 50 most up- and down-regulated mRNAs, respectively, corresponded to genes which expression has been previously associated with osteoblastic differentiation process. Thus, osteoblast specific cadherin 11 which mediates the differentiation of mesenchymal cells into osteoblastic cells is up-regulated in B02. While S100A4, recently described as a key negative regulator of osteoblast differentiation, is the most down-regulated gene in B02 cells. RT-PCR and western blotting experiments allowed the validation of the modulation of several genes of interest. Using immunohistochemistry, performed on human breast primary tumors and their matched liver and bone metastases, we were able to confirm that the osteoblast-like pattern of gene expression observed in our model holds true in vivo. This is the first report demonstrating a gene-expression pattern corresponding to the acquisition of an osteomimetic phenotype by bone metastatic breast cancer cells.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, pubmed, cas, bone, article, cancer, cells, differentiation, res, breast, human, expression, cell, osteoblast, miner, gene, growth, research, factor, protein, development, bellahcène, osteoblastic, vitro, osteoblasts, analysis, metastasis, metastases, prostate, formation, morphogenetic, phenotype, castronovo, matrix, proteins, mesenchymal, tissue, genes, van, biol, university, metastatic, vivo, sialoprotein, mice, biochem, privacy, cookies, content,

Topics {✒️}

stromal-derived factor-1 promotes month download article/chapter igfbp-4 protease-dependent mechanism tumor necrosis factor-alpha camp-pka signaling pathway cell–cell interaction mediated parathyroid hormone-related protein estrogen receptor-responsive gene bone-seeking clone exhibits de jesus-escobar jm inter-university attraction pole murine mc3t3-e1 cells human breast cancer osteoblastic mc3t3-e1 cells gene expression profiling s100a4 calcium-binding protein genome-wide expression analysis osteoblast-specific gene expression breast cancer cells mesenchymal stem cells human breast tumors full article pdf bone morphogenetic proteins bmp-2-mediated osteoblast differentiation prostate cancer cells bone morphogenetic protein-2 bone morphogenetic protein-7 prostate cancer metastasis human fetal osteoblasts connexin43-null osteoblasts early-phase osteoblast differentiation metastasis research laboratory experimental cancer research specific transcription factors privacy choices/manage cookies human osteoblastic cells bone matrix proteins related subjects bisphosphonate zoledronic acid duarte wr transcriptome analysis reveals mc3t3-e1 cells franceschi rt bone matrix protein noggin-overexpressing mice form bone metastases bone metastases compared neoplastic human tissues human osteocalcin promoter �télévie” research fellow

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells
         description:Metastatic breast cancer cells exhibit the selective ability to seed and grow in the skeleton. We and others have previously reported that human breast tumors which metastasize to the skeleton overexpress bone matrix extracellular proteins. In an attempt to reveal the osteoblast-like phenotype of osteotropic breast cancer cells, we performed a microarray study on a model of breast cancer bone metastasis consisting of the MDA-MB-231 human cell line and its variant B02 selected for its high capacity to form bone metastases in vivo. Analysis of B02 cells transcriptional profile revealed that 11 and 9 out of the 50 most up- and down-regulated mRNAs, respectively, corresponded to genes which expression has been previously associated with osteoblastic differentiation process. Thus, osteoblast specific cadherin 11 which mediates the differentiation of mesenchymal cells into osteoblastic cells is up-regulated in B02. While S100A4, recently described as a key negative regulator of osteoblast differentiation, is the most down-regulated gene in B02 cells. RT-PCR and western blotting experiments allowed the validation of the modulation of several genes of interest. Using immunohistochemistry, performed on human breast primary tumors and their matched liver and bone metastases, we were able to confirm that the osteoblast-like pattern of gene expression observed in our model holds true in vivo. This is the first report demonstrating a gene-expression pattern corresponding to the acquisition of an osteomimetic phenotype by bone metastatic breast cancer cells.
         datePublished:2006-10-07T00:00:00Z
         dateModified:2006-10-07T00:00:00Z
         pageStart:135
         pageEnd:148
         sameAs:https://doi.org/10.1007/s10549-006-9279-8
         keywords:
            Bone
            Breast cancer
            Metastases
            Osteoblast
            Osteomimicry
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:101
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:A. Bellahcène
               affiliation:
                     name:University of Liège
                     address:
                        name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:R. Bachelier
               affiliation:
                     name:INSERM Unit Research 664
                     address:
                        name:INSERM Unit Research 664, Lyon, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Detry
               affiliation:
                     name:University of Liège
                     address:
                        name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Lidereau
               affiliation:
                     name:INSERM Unit Research 735/Centre René Huguenin
                     address:
                        name:INSERM Unit Research 735/Centre René Huguenin, St-Cloud, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Clézardin
               affiliation:
                     name:INSERM Unit Research 664
                     address:
                        name:INSERM Unit Research 664, Lyon, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:V. Castronovo
               affiliation:
                     name:University of Liège
                     address:
                        name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells
      description:Metastatic breast cancer cells exhibit the selective ability to seed and grow in the skeleton. We and others have previously reported that human breast tumors which metastasize to the skeleton overexpress bone matrix extracellular proteins. In an attempt to reveal the osteoblast-like phenotype of osteotropic breast cancer cells, we performed a microarray study on a model of breast cancer bone metastasis consisting of the MDA-MB-231 human cell line and its variant B02 selected for its high capacity to form bone metastases in vivo. Analysis of B02 cells transcriptional profile revealed that 11 and 9 out of the 50 most up- and down-regulated mRNAs, respectively, corresponded to genes which expression has been previously associated with osteoblastic differentiation process. Thus, osteoblast specific cadherin 11 which mediates the differentiation of mesenchymal cells into osteoblastic cells is up-regulated in B02. While S100A4, recently described as a key negative regulator of osteoblast differentiation, is the most down-regulated gene in B02 cells. RT-PCR and western blotting experiments allowed the validation of the modulation of several genes of interest. Using immunohistochemistry, performed on human breast primary tumors and their matched liver and bone metastases, we were able to confirm that the osteoblast-like pattern of gene expression observed in our model holds true in vivo. This is the first report demonstrating a gene-expression pattern corresponding to the acquisition of an osteomimetic phenotype by bone metastatic breast cancer cells.
      datePublished:2006-10-07T00:00:00Z
      dateModified:2006-10-07T00:00:00Z
      pageStart:135
      pageEnd:148
      sameAs:https://doi.org/10.1007/s10549-006-9279-8
      keywords:
         Bone
         Breast cancer
         Metastases
         Osteoblast
         Osteomimicry
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:101
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:A. Bellahcène
            affiliation:
                  name:University of Liège
                  address:
                     name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:R. Bachelier
            affiliation:
                  name:INSERM Unit Research 664
                  address:
                     name:INSERM Unit Research 664, Lyon, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Detry
            affiliation:
                  name:University of Liège
                  address:
                     name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Lidereau
            affiliation:
                  name:INSERM Unit Research 735/Centre René Huguenin
                  address:
                     name:INSERM Unit Research 735/Centre René Huguenin, St-Cloud, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Clézardin
            affiliation:
                  name:INSERM Unit Research 664
                  address:
                     name:INSERM Unit Research 664, Lyon, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:V. Castronovo
            affiliation:
                  name:University of Liège
                  address:
                     name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:101
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Liège
      address:
         name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
         type:PostalAddress
      name:INSERM Unit Research 664
      address:
         name:INSERM Unit Research 664, Lyon, France
         type:PostalAddress
      name:University of Liège
      address:
         name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
         type:PostalAddress
      name:INSERM Unit Research 735/Centre René Huguenin
      address:
         name:INSERM Unit Research 735/Centre René Huguenin, St-Cloud, France
         type:PostalAddress
      name:INSERM Unit Research 664
      address:
         name:INSERM Unit Research 664, Lyon, France
         type:PostalAddress
      name:University of Liège
      address:
         name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:A. Bellahcène
      affiliation:
            name:University of Liège
            address:
               name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:R. Bachelier
      affiliation:
            name:INSERM Unit Research 664
            address:
               name:INSERM Unit Research 664, Lyon, France
               type:PostalAddress
            type:Organization
      name:C. Detry
      affiliation:
            name:University of Liège
            address:
               name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
               type:PostalAddress
            type:Organization
      name:R. Lidereau
      affiliation:
            name:INSERM Unit Research 735/Centre René Huguenin
            address:
               name:INSERM Unit Research 735/Centre René Huguenin, St-Cloud, France
               type:PostalAddress
            type:Organization
      name:P. Clézardin
      affiliation:
            name:INSERM Unit Research 664
            address:
               name:INSERM Unit Research 664, Lyon, France
               type:PostalAddress
            type:Organization
      name:V. Castronovo
      affiliation:
            name:University of Liège
            address:
               name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
      name:INSERM Unit Research 664, Lyon, France
      name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
      name:INSERM Unit Research 735/Centre René Huguenin, St-Cloud, France
      name:INSERM Unit Research 664, Lyon, France
      name:Metastasis Research Laboratory, Center of Experimental Cancer Research, University of Liège, Liège, Belgium
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(278)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.14s.

LINK . SPRINGER . COM {}